Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.63 |
| ▸ | MAOA | P21397 | 4/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | AR | P10275 | 4/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9472016 | 0.90 | CYP19A1 (0.62) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL1377229 | 0.90 | CYP19A1 (0.62) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL29390509 | 0.88 | CYP19A1 (0.65) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL4581525 | 0.88 | CYP19A1 (0.65) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL29688449 | 0.84 | ALDH1A1 (0.62) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL1377135 | 0.84 | ALDH1A1 (0.62) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL18170274 | 0.84 | CYP19A1 (0.61) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL9747026 | 0.82 | ALDH1A1 (0.65) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL20511087 | 0.82 | CYP19A1 (0.56) | MAOBMAOACYP19A1ALDH1A1HPGD | |
| SCHEMBL523446 | 0.82 | ALDH1A1 (0.65) | MAOBMAOACYP19A1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121588908-B | Catalyst for in-situ degradation of COD (chemical oxygen demand) of wastewater and preparation method thereof | 成都昊宏水处理技术有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-121588908-B | Catalyst for in-situ degradation of COD (chemical oxygen demand) of wastewater and preparation method thereof | 成都昊宏水处理技术有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-8530607-B2 | Aromatic ether and alkynyl containing phthalonitriles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-09-10 | — | — | US | disclosed |
| US-20110288254-A1 | AROMATIC ETHER AND ALKYNYL CONTAINING PHTHALONITRILES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2011-11-24 | — | — | US | disclosed |
| US-8039576-B2 | Aromatic ether and alkynyl containing phthalonitriles | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2011-10-18 | — | — | US | disclosed |
| US-20090069484-A1 | AROMATIC ETHER AND ALKYNYL CONTAINING PHTHALONITRILES | THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288254-A1 | AROMATIC ETHER AND ALKYNYL CONTAINING PHTHALONITRILES | PNN, BECN1, ACIN1 | MAOB 4135/4885MAOA 4110/4885CYP19A1 3314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.